The ADAPTABLE Study Needs You!

ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness)  is a three-year pragmatic clinical trial that will compare the effectiveness of two different daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease.

Be part of pragmatic trials that are designed to reflect “real-world” medical care by recruiting unique populations of patients, ingraining the trial into the usual healthcare setting, and utilizing data from health systems to produce results that are used to improve patient care.  You can make a difference in healthcare!

Watch this video to find out more.

The ADAPTABLE study is now recruiting as many as 20,000 patients with heart disease.  For more information on the ADAPTABLE study and how to participate, visit the study site or contact:

Charon Gladfelter, Research Project Coordinator

charon.gladfelter@northwestern.edu

312.503.4279

« Back To News

Join Us

CHIP collaborators are part of the public, private and nonprofit sectors and have an interest in working toward a world where health outcomes are improved because data is used effectively.

Get in Touch

Join Our Mailing List


Don't Forget To Connect